By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere announced on Tuesday after the close of the market that it has settled a patent dispute with Eppendorf for $4 million, and as a result acquired certain patents and the patent rights on a global basis.

Eppendorf also received a limited license to service its existing customers as part of the settlement. Licenses previously issued by Eppendorf to other companies and that relate to the purchased patents and patent rights remain in effect.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.